Role of Radioembolization for Biliary Tract and Primary Liver Cancer
| Autor: | Amy C. Taylor, Dilip Rajasekhar Maddirela, Sarah B. White |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Percutaneous Tare weight medicine.medical_treatment Transarterial Radioembolization Muscle hypertrophy 03 medical and health sciences 0302 clinical medicine medicine Humans Intrahepatic Cholangiocarcinoma business.industry Liver Neoplasms Prognosis medicine.disease Ablation Embolization Therapeutic Biliary Tract Neoplasms Oncology Biliary tract 030220 oncology & carcinogenesis Hepatocellular carcinoma 030211 gastroenterology & hepatology Surgery Radiology business |
| Zdroj: | Surgical Oncology Clinics of North America. 28:731-743 |
| ISSN: | 1055-3207 |
| DOI: | 10.1016/j.soc.2019.07.001 |
| Popis: | Hepatocellular carcinoma and intrahepatic cholangiocarcinoma are often amenable to locoregional therapy, including percutaneous ablation, transarterial chemoembolization (TACE), or transarterial radioembolization (TARE). TARE is a technique that delivers a high dose of radiation to the tumor, while limiting the dose to the normal liver parenchyma and the adjacent organs. It has been shown to effectively provide disease control with relatively few toxicities, and in certain cases results in a complete response. It is the preferred therapy as a bridge to liver transplant and can provide necessary compensatory future liver remnant hypertrophy before planned surgical resection. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|